News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
343,921 Results
Type
Article (20898)
Company Profile (141)
Press Release (322871)
Multimedia
Podcasts (107)
Webinars (17)
Section
Business (105864)
Career Advice (891)
Deals (18638)
Drug Delivery (105)
Drug Development (51016)
Employer Resources (80)
FDA (7824)
Job Trends (7818)
News (186839)
Policy (17465)
Tag
Academia (738)
Accelerated approval (14)
Adcomms (22)
Allergies (73)
Alliances (27976)
ALS (81)
Alzheimer's disease (768)
Antibody-drug conjugate (ADC) (179)
Approvals (7949)
Artificial intelligence (253)
Autoimmune disease (60)
Automation (12)
Bankruptcy (178)
Best Places to Work (5557)
BIOSECURE Act (14)
Biosimilars (155)
Biotechnology (60)
Bladder cancer (70)
Brain cancer (32)
Breast cancer (225)
Cancer (2094)
Cardiovascular disease (217)
Career advice (737)
Career pathing (24)
CAR-T (98)
CDC (14)
Cell therapy (258)
Cervical cancer (11)
Clinical research (44464)
Collaboration (864)
Company closure (1)
Compensation (335)
Complete response letters (47)
COVID-19 (1144)
CRISPR (45)
C-suite (449)
Cystic fibrosis (85)
Data (2987)
Decentralized trials (2)
Denatured (26)
Depression (70)
Diabetes (229)
Diagnostics (1879)
Digital health (14)
Diversity (8)
Diversity, equity & inclusion (22)
Drug discovery (152)
Drug pricing (181)
Drug shortages (33)
Duchenne muscular dystrophy (123)
Earnings (40768)
Editorial (42)
Employer branding (10)
Employer resources (78)
Events (50656)
Executive appointments (608)
FDA (9204)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (592)
Gene editing (82)
Generative AI (28)
Gene therapy (241)
GLP-1 (775)
Government (1997)
Grass and pollen (4)
Guidances (202)
Healthcare (5920)
HIV (25)
Huntington's disease (20)
IgA nephropathy (55)
Immunology and inflammation (153)
Immuno-oncology (20)
Indications (49)
Infectious disease (1266)
Inflammatory bowel disease (110)
Inflation Reduction Act (11)
Influenza (40)
Intellectual property (118)
Interviews (118)
IPO (7419)
IRA (52)
Job creations (2443)
Job search strategy (653)
Kidney cancer (10)
Labor market (58)
Layoffs (340)
Leadership (26)
Legal (4148)
Liver cancer (35)
Longevity (7)
Lung cancer (314)
Lymphoma (195)
Machine learning (19)
Management (31)
Manufacturing (454)
MASH (96)
Medical device (2014)
Medtech (2019)
Mergers & acquisitions (11689)
Metabolic disorders (791)
Multiple sclerosis (87)
NASH (20)
Neurodegenerative disease (139)
Neuropsychiatric disorders (57)
Neuroscience (1403)
NextGen: Class of 2025 (2361)
Non-profit (916)
Now hiring (41)
Obesity (455)
Opinion (226)
Ovarian cancer (58)
Pain (125)
Pancreatic cancer (82)
Parkinson's disease (141)
Partnered (16)
Patents (254)
Patient recruitment (184)
Peanut (19)
People (34312)
Pharmaceutical (76)
Pharmacy benefit managers (30)
Phase I (13986)
Phase II (18761)
Phase III (15094)
Pipeline (2105)
Policy (218)
Postmarket research (1619)
Preclinical (4912)
Press Release (29)
Prostate cancer (120)
Psychedelics (24)
Radiopharmaceuticals (171)
Rare diseases (447)
Real estate (3203)
Recruiting (33)
Regulatory (13474)
Reports (25)
Research institute (832)
Resumes & cover letters (141)
Rett syndrome (3)
RNA editing (9)
RSV (40)
Schizophrenia (108)
Series A (105)
Series B (72)
Service/supplier (7)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (115)
Sponsored (18)
Startups (2034)
State (2)
Stomach cancer (11)
Supply chain (69)
Tariffs (91)
The Weekly (79)
Vaccines (382)
Venture capital (55)
Weight loss (339)
Women's health (32)
Worklife (8)
Date
Today (60)
Last 7 days (311)
Last 30 days (1292)
Last 365 days (15546)
2025 (15006)
2024 (17683)
2023 (19669)
2022 (25875)
2021 (26644)
2020 (24881)
2019 (20061)
2018 (15593)
2017 (17259)
2016 (16208)
2015 (18813)
2014 (14794)
2013 (12555)
2012 (13487)
2011 (13820)
2010 (12742)
Location
Africa (415)
Alabama (38)
Alaska (1)
Arizona (88)
Arkansas (8)
Asia (25721)
Australia (3311)
California (4407)
Canada (1709)
China (651)
Colorado (175)
Connecticut (180)
Delaware (164)
Europe (53169)
Florida (766)
Georgia (94)
Hawaii (1)
Idaho (18)
Illinois (399)
India (44)
Indiana (275)
Iowa (3)
Japan (270)
Kansas (81)
Kentucky (28)
Louisiana (5)
Maine (4)
Maryland (572)
Massachusetts (3588)
Michigan (62)
Minnesota (223)
Mississippi (3)
Missouri (40)
Montana (12)
Nebraska (12)
Nevada (35)
New Hampshire (8)
New Jersey (1743)
New Mexico (21)
New York (1214)
North Carolina (733)
North Dakota (2)
Northern California (2025)
Ohio (117)
Oklahoma (8)
Oregon (22)
Pennsylvania (984)
Puerto Rico (17)
Rhode Island (25)
South America (612)
South Carolina (10)
Southern California (1862)
Tennessee (60)
Texas (600)
United States (16884)
Utah (90)
Virginia (161)
Washington D.C. (57)
Washington State (346)
West Virginia (1)
Wisconsin (42)
Wyoming (1)
343,921 Results for "verona pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merck Completes Acquisition of Verona Pharma
October 8, 2025
·
8 min read
Press Releases
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
September 25, 2025
·
7 min read
Press Releases
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
September 16, 2025
·
4 min read
Press Releases
Verona Pharma Announces June 2025 Investor Conference Participation
May 21, 2025
·
1 min read
FDA
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
June 26, 2024
·
10 min read
Press Releases
Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
March 31, 2025
·
6 min read
Press Releases
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
May 6, 2025
·
6 min read
Press Releases
Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
April 29, 2025
·
15 min read
Press Releases
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
July 9, 2025
·
17 min read
Press Releases
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
April 15, 2025
·
1 min read
1 of 34,393
Next
